TETRAMAB Trademark

Serial Number: 98559594

TETRAMAB is a trademark filed by Aarvik Therapeutics, Inc. on May 20, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently no longer active.

Trademark Classes

1

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

16

Class 16 - Paper Goods

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Owner Contact Info

Aarvik Therapeutics, Inc. (7 trademarks)

Hayward, CA 94544

Entity Type: 03

Legal Representation

Attorney of Record

Christopher D. Olszyk, Jr.

2,106 trademarks filed View all →

Correspondence Address

Christopher D. Olszyk, Jr. Fox Rothschild LLP

997 Lenox Drive, Bldg. 3

Lawrenceville, NJ 08643-2311

United States

Trademark Details

Filing Date

May 20, 2024

Registration Date

Not Registered

Goods & Services

Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes

Printed educational and informational publications related to cancer, immunological, inflammatory and neurological disorders, namely, pamphlets, newsletters, guides

Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research

Providing healthcare information regarding the treatment of cancer, immunological, inflammatory and neurological disorders; Providing healthcare information regarding drugs for the treatment of cancer, immunological, inflammatory and neurological disorders

Providing prescription drug research information relating to drugs for the diagnosis and treatment of cancer, immunological, inflammatory and neurological disorders